Table 2 Clinical characteristics of HIV patients with or without chronic non HBV/HCV hepatitis at baseline visit**
Clinical parameters | Case | Control | p value |
|---|---|---|---|
(n = 124) | (n = 124) | ||
Male sex (n,%) | 65(52.4) | 37(29.8) | 0.001* |
Mean age (years), ± SD | 32.7 ± 7.4 | 33.3 ± 7.2 | 0.56 |
o ≤ 25 (n,%) | 16(12.9) | 12(9.7) | 0.85 |
o 25–34.9 (n,%) | 68(54.8) | 70(56.4) | |
o 35–44.9 (n,%) | 31(25.0) | 34(27.4) | |
o ≥ 45 (n,%) | 9(7.3) | 8(6.5) | |
BMI ≥ 23 kg/m2 (n,%) | 39(31.4) | 27(21.8) | 0.09 |
Elevated blood pressure/ hypertension (n,%) | 18(14.5) | 18(14.5) | 1.00 |
Metabolic syndrome (n,%) | 9(7.3) | 3(2.4) | 0.08 |
Sexual risk behavior (n,%) | 0.08 | ||
o Heterosexual | 83(66.9) | 98(79.0) | |
o MSM | 37(29.9) | 23(18.6) | |
o Others | 4(3.2) | 3(2.4) | |
CDC classification (n,%) | 0.21 | ||
o Category A or B | 110(88.7) | 117(94.4) | |
o Category C | 14(11.3) | 7(5.6) | |
Laboratory measurement (n,%) | |||
o CD4+ cell count ≤ 200 cells/mm3 | 53(42.7) | 50(40.3) | 0.66 |
o Nadir CD4+ cell count ≤ 200 cells/mm3 | 67(54) | 67(54) | 1.00 |
o HIV-1 RNA level ≥ 5 log 10 copies/ml | 41(33.1) | 31(25) | 0.13 |
o Impaired fasting plasma glucose ≥ 100 mg/dL | 21(16.9) | 16(12.9) | 0.87 |
o Total cholesterol ≥ 200 mg/dL | 25(22.7) | 27(24.1) | 0.87 |
o Triglycerides ≥ 150 mg/dL | 25(22.7) | 26(23.2) | 0.88 |
o HDL cholesterol ≤ 40 mg/dL (male) or ≤ 50 mg/dL (female) | 55(51.4) | 57(52.3) | 0.70 |
o LDL cholesterol ≥ 130 mg/dL | 2(1.8) | 1(0.9) | 0.57 |
Median, duration of study (years) (IQR) | 9.6(6.7–11.9) | 9.6(6.7–11.9) | 0.97 |